About Smoking Cessation Products
Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death. This is encouraging people to adopt smoking cessation products. Public awareness programs help create awareness about the hazards of smoking, and also the availability of products that help quit smoking.
Technavio’s analysts forecast the global smoking cessation products market to grow at a CAGR of 18.16% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global smoking cessation products market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, off-label, and over-the-counter (OTC) products used for smoking cessation.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Smoking Cessation Products Market 2016-2020
Technavio recognizes the following companies as the key players in the global smoking cessation products market: GlaxoSmithKline, Imperial Tobacco, NJOY, Pfizer, and Reynolds American.
Other Prominent Vendors in the market are: 22nd Century Group, Alkalon, Altria Group, Aradigm, Arena Pharmaceuticals, Ballantyne Brands, British American Tobacco (BAT), CB Distributors, Cytos Biotechnology, Electronics Cigarettes International Group (Victory Electronic Cigarettes), Evotec, Gamucci, Japan Tobacco, Johnson & Johnson, LOGIC Technology, NAL Pharmaceuticals, Nicotek, Novartis, Revolymer, RR Chemicals, Selecta Biosciences, Target, The Harvard Drug Group, Vapor, VMR Products, Walgreens, Wal-Mart, and White Cloud.
Commenting on the report, an analyst from Technavio’s team said: “A ban on tobacco advertisements around the world has had a positive effect on consumers. The report showed a decline of at least 16% in tobacco consumption compared to the pre-ban days. However, only 29 countries, which constitute 12% of the world's population, have banned these advertisements. Globally, one-third of countries have imposed a minimal restriction on tobacco advertisements and campaigns. It is estimated that around 78% of youngsters aged 13-15 years are exposed to advertisement or promotions for tobacco, leading them to experiment with the product.”
According to the report, more people are becoming aware of the risks associated with tobacco use. Around six million users of tobacco die every year and this number is set to increase to eight million by 2030. Cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases are also caused due to tobacco use. Tobacco smoke consists of over 4,000 chemical compounds, with about 69 chemicals that are potentially known to cause cancer. These chemicals harm not only smokers, but also second-hand smokers who inhale the smoke in public spaces. Another area where the harmful effects of tobacco are witnessed are in tobacco farming, where young children from underprivileged families are often employed.
Further, the report states that the side effects associated with drugs and therapies may hinder market growth.
GlaxoSmithKline, Imperial Tobacco, NJOY, Pfizer, Reynolds American, 22nd Century Group, Alkalon, Altria Group, Aradigm, Arena Pharmaceuticals, Ballantyne Brands, British American Tobacco (BAT), CB Distributors, Cytos Biotechnology, Electronics Cigarettes International Group (Victory Electronic Cigarettes), Evotec, Gamucci, Japan Tobacco, Johnson & Johnson, LOGIC Technology, NAL Pharmaceuticals, Nicotek, Novartis, Revolymer, RR Chemicals, Selecta Biosciences, Target, The Harvard Drug Group, Vapor, VMR Products, Walgreens, Wal-Mart, White Cloud.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook